• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 451/14 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamineCyclic acetals thereof containing 9-azabicyclo [3.3.1] nonane ring systems, e.g. granatane, 2-aza-adamantaneCyclic acetals thereof

Patent holdings for IPC class C07D 451/14

Total number of patents in this class: 162

10-year publication summary

8
11
21
19
11
10
10
6
9
2
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Skyhawk Therapeutics, Inc.
151
20
Theravance Biopharma R&D IP, LLC
362
14
Purdue Pharma L.P.
480
10
Nxera Pharma UK Limited
185
8
Merck Patent GmbH
5729
5
Nippon Soda Co., Ltd.
882
5
Nissan Chemical Industries, Ltd.
1643
5
Washington University
1743
5
The Regents of the University of California
20778
4
The Scripps Research Institute
1340
4
Knoa Pharma LLC, Purdue Pharma, Inc., Corporation, Delaware
28
4
Novartis AG
10251
3
Agency for Science, Technology and Research
3736
3
Astraea Therapeutics, LLC
12
3
Shionogi & Co., Ltd.
880
3
Tohoku Techno Arch Co., Ltd.
122
3
Tohoku University
2981
3
Arthrosi Therapeutics, Inc.
28
3
F. Hoffmann-La Roche AG
7819
2
Bayer Pharma AG
1009
2
Other owners 53